Persistent Antiphospholipid Antibodies Are Not Associated With Worse Clinical Outcomes in a Prospective Cohort of Hospitalised Patients With SARS-CoV-2 Infection

OBJECTIVE: Patients with COVID-19 presented with an elevated prevalence of antiphospholipid antibodies (aPL) but the relationship with thrombosis is controversial. We analysed the persistence of aPL and their association with the clinical outcomes during hospitalisation in a cohort of COVID-19 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Espinosa, Gerard, Zamora-Martínez, Carles, Pérez-Isidro, Albert, Neto, Daniela, Bravo-Gallego, Luz Yadira, Prieto-González, Sergio, Viñas, Odette, Moreno-Castaño, Ana Belen, Ruiz-Ortiz, Estíbaliz, Cervera, Ricard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257245/
https://www.ncbi.nlm.nih.gov/pubmed/35812410
http://dx.doi.org/10.3389/fimmu.2022.911979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257245/
https://www.ncbi.nlm.nih.gov/pubmed/35812410
http://dx.doi.org/10.3389/fimmu.2022.911979

Ejemplares similares